Table 4.
Sensitization of MRP1-Expressing PC-3rVCR20 Cells to Vincristine by Saq, Saq-NO, or MK571 (MRP1 Inhibitor).
| IC50* Vincristine | Fold Sensitization† | |
| Vincristine | 33.10 ± 4.07 | |
| Vincristine + MK571 10 µM | 12.54 ± 1.88‡ | 3.7 |
| Vincristine + saq 5 µM | 4.28 ± 0.61‡ | 7.7 |
| Vincristine + saq 2.5 µM | 8.76 ± 1.19‡ | 3.8 |
| Vincristine + saq-NO 5 µM | 2.73 ± 0.42‡,§ | 12.1 |
| Vincristine + saq-NO 2.5 µM | 4.51 ± 0.73‡,§ | 7.3 |
Values are mean ± SD from three independent experiments.
Concentration that decreases cell viability by 50%.
IC50 vincristine/IC50 vincristine + saq, saq-NO, or MK571.
P < .05 relative to vincristine alone.
P < .05 relative to vincristine + corresponding saq concentration.